o2h ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Monument Therapeutics
25 Feb 2025
Monument Therapeutics secures £850k led by ACF Investors to advance schizophrenia treatment with MT1988
Monument Therapeutics applies digital biomarkers to psychiatric drug development, advancing combination therapies designed to improve cognitive impairment in schizophrenia alongside existing antipsychotic treatments.
Atelerix
28 Jan 2025
Atelerix lands £750k from ACF Investors and o2h ventures to revolutionise biological transport
Atelerix develops hydrogel technology that allows biological samples to be stored and shipped at ambient temperatures while maintaining cell viability.
o2h ventures
More venture news
- 11 May 2026
KaizanKaizan secures £2.5m in funding led by Pembroke VCT for AI platform helping services firms grow client relationships
EquitySales - 11 May 2026
EskEsk lands £2.6m in funding led by Maven Capital Partners to turn film, TV and games IP into global live shows
EquityMedia & Entertainment - 8 May 2026
Quinas TechnologyQuinas Technology secures funding from Malta Government Venture Capital for ultra-low power semiconductor memory technology
EquityDeep Tech
